Search

Your search keyword '"Mahnkopf Christian"' showing total 231 results

Search Constraints

Start Over You searched for: Author "Mahnkopf Christian" Remove constraint Author: "Mahnkopf Christian"
231 results on '"Mahnkopf Christian"'

Search Results

1. Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of life

2. Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trial

10. Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial

11. Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design

13. Abstract 12367: Sex-Specific Differences in Quality of Life and Atrial Fibrillation Recurrence Following Ablation of Persistent Atrial Fibrillation: Insights From the DECAAF II Trial

14. Abstract 12357: Investigating Sex-Specific Factors Influencing Atrial Fibrillation Burden in Patients With Persistent Atrial Fibrillation: A DECAAF II Subanalysis

19. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial

20. Feasibility and Efficacy of Transcatheter Tricuspid Valve Repair in Patients with Cardiac Implanted Electrical Devices and Trans-Tricuspid Leads

23. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY

24. Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation

29. PO-04-142 BASELINE NATRIURETIC PEPTIDES IS A STRONG MARKER OF ATRIAL REMODELING IN NON-HEART FAILURE PATIENTS WITH PERSISTENT AF UNDERGOING PULMONARY VEIN ISOLATION

30. PO-03-090 IMPACT OF ABLATION ENERGY AND SUBSTRATE MODIFICATION ON REGRESSION FROM PERSISTENT ATRIAL FIBRILLATION TO PAROXYSMAL ATRIAL FIBRILLATION

31. PO-03-132 DIRECT CATHETER ABLATION VERSUS CATHETER ABLATION POST ANTIARRHYTHMIC DRUG THERAPY FOR PERSISTENT ATRIAL FIBRILLATION: EFFECT ON ARRHYTHMIA RECURRENCE, AF BURDEN, EARLY LEFT ATRIUM REMODELING AND QUALITY OF LIFE

32. PO-03-131 AGE-RELATED LEFT ATRIAL REMODELING AND EFFICACY OF CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION

33. PO-03-129 LESSONS LEARNED FROM VARIATION IN RADIOFREQUENCY ENERGY DELIVERY SETTINGS IN A MULTICENTER RANDOMIZED TRIAL: IMPORTANCE OF POWER AND DURATION

35. BASELINE NATRIURETIC PEPTIDES AND LEFT ATRIAL VOLUME ARE THE STRONGEST PREDICTORS OF AF BURDEN IN NON-HEART FAILURE PATIENTS WITH PERSISTENT AF UNDERGOING PULMONARY VEIN ISOLATION

36. MACHINE LEARNING-BASED CLUSTER ANALYSIS IDENTIFIES PATIENT PHENOTYPES FOR RISK OF ATRIAL ARRHYTHMIA RECURRENCE FOLLOWING CATHETER ABLATION IN PAROXYSMAL ATRIAL FIBRILLATION

40. MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF Study

46. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF Study

47. Computational modeling identifies embolic stroke of undetermined source patients with potential arrhythmic substrate

48. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.

49. Author response: Computational modeling identifies embolic stroke of undetermined source patients with potential arrhythmic substrate

50. Effects of Environmental Factors on Severity and Mortality of COVID-19

Catalog

Books, media, physical & digital resources